Modelling hepatitis C virus infection and the development of hepatocellular carcinoma

被引:7
|
作者
Chakrabarty, Siddhartha P. [1 ]
Murray, John M. [2 ,3 ]
机构
[1] Indian Inst Technol Guwahati, Dept Math, Gauhati 781039, Assam, India
[2] Univ New S Wales, Sch Math & Stat, Sydney, NSW 2052, Australia
[3] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia
关键词
Hepatitis C; Hepatocellular carcinoma; Ordinary differential equation; Stochastic model; Latin hypercube sampling; VIRAL DYNAMICS; LIVER-TRANSPLANTATION; RESPONSES; HEPATOCARCINOGENESIS; CLEARANCE; EFFICACY; INDIA;
D O I
10.1016/j.jtbi.2012.03.030
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
While mathematical models exist describing the dynamics of hepatitis C virus (HCV), most of them focus on the short term dynamics after the commencement of antiviral therapy. This work is the first attempt at mathematically modelling the full course of HCV infection and the impact that these viral and immune processes have on the progression to hepatocellular carcinoma (HCC). This model is based on the premise that these long term conditions are ultimately random and likely driven by the cell-mediated immune response. The risk of cancer arising is modelled through a stochastic model that incorporates the dynamics of HCV over the course of infection. Our model simulations produce approximately 9% prevalence of HCC in individuals after 40 years, consistent with the literature estimates. We find that higher viral infectivity leads to a greater likelihood of developing HCC (p <0.0001), but it does not determine the speed with which it arises. This infectivity drives the level of immune response, the amount of hepatocyte proliferation, and the risk of a mutational event. In our simulations the probability of developing HCC increases approximately linearly with duration of infection at the rate of 2.4 incident cases per thousand HCV-infected person years. This indicates that the sooner viral replication can be suppressed through antiviral therapy, the greater the chance of forestalling HCC. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 50 条
  • [41] GB virus C/hepatitis G virus infection in Chinese patients with hepatocellular carcinoma
    Lei, XZ
    Shigeko, N
    Deng, XW
    Zhao, LS
    Akahane, Y
    HEPATOLOGY RESEARCH, 2000, 16 (02) : 91 - 97
  • [42] Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
    Morgan, Rebecca L.
    Baack, Brittney
    Smith, Bryce D.
    Yartel, Anthony
    Pitasi, Marc
    Falck-Ytter, Yngve
    ANNALS OF INTERNAL MEDICINE, 2013, 158 (05) : 329 - +
  • [43] Effect of interferon therapy on development of hepatocellular carcinoma and diseases progression in patients with hepatitis C virus infection
    Choi, Jong Young
    Tak, Won Young
    Choi, Sung Kyu
    Heo, Jung
    Kweon, Young Oh
    Bae, Si Hyun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A30 - A30
  • [44] Large cell dysplasia in cirrhosis secondary to hepatitis C virus infection: A predictor of the development of hepatocellular carcinoma?
    Yantiss, RK
    Sheth, SG
    Resnick, RH
    Chopra, S
    Afdhal, NA
    Nasser, IA
    LABORATORY INVESTIGATION, 2002, 82 (01) : 297A - 297A
  • [45] Large cell dysplasia in cirrhosis secondary to hepatitis C virus infection: A predictor of the development of hepatocellular carcinoma?
    Yantiss, RK
    Sheth, SG
    Resnick, RH
    Chopra, S
    Afdhal, NA
    Nasser, IA
    MODERN PATHOLOGY, 2002, 15 (01) : 297A - 297A
  • [46] HEPATITIS-C VIRUS GENOTYPES AND DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA
    YOTSUYANAGI, H
    KOIKE, K
    YASUDA, K
    MORIYA, K
    HINO, K
    KUROKAWA, K
    IINO, S
    CANCER, 1995, 76 (08) : 1352 - 1355
  • [47] Hepatitis C virus infection with hepatocellular carcinoma: Not a controversial indication for liver transplantation
    Rodriguez-Luna, H
    Balan, V
    Sharma, P
    Byrne, T
    Mulligan, D
    Rakela, J
    Vargas, HE
    TRANSPLANTATION, 2004, 78 (04) : 580 - 583
  • [48] Effect of Aging on Risk for Hepatocellular Carcinoma in Chronic Hepatitis C Virus Infection
    Asahina, Yasuhiro
    Tsuchiya, Kaoru
    Tamaki, Nobuharu
    Hirayama, Itsuko
    Tanaka, Tomohiro
    Sato, Mitsuaki
    Yasui, Yutaka
    Hosokawa, Takanori
    Ueda, Ken
    Kuzuya, Teiji
    Nakanishi, Hiroyuki
    Itakura, Jun
    Takahashi, Yuka
    Kurosaki, Masayuki
    Enomoto, Nobuyuki
    Izumi, Namiki
    HEPATOLOGY, 2010, 52 (02) : 518 - 527
  • [49] Treatment of hepatitis C virus infection in patients with hepatocellular carcinoma: Truth or dare?
    Mocan, Tudor
    Nenu, Iuliana
    Craciun, Rares
    Sparchez, Zeno
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (06) : 1518 - 1528